chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pfizer Dose 1 3/10/21 (EN6205 Pfizer Dose 2 4/7/21 (EN6208) COVID Positive 1/29/22  1/29/22: Patient is a 68-year-old female who presents from the nursing home with increasing shortness of breath, hypoxia and COVID positive.  A full history of present illness could not be had as the patient is nonverbal since having a hemorrhagic stroke with resultant left-sided hemiplegia and the past patient also is NPO and has a G-tube.  Patient was found to be having hypoxia at the nursing home with O2 saturations in the 80% range, it is believed that the patient is chronically on supplemental O2 via nasal cannula.  EMS were notified who did give the patient a nebulizer treatment and increased her oxygen which improved her saturations into the low 90s.  No further information could be had from the patient.  The patient's medical history, current medications, imaging studies, vital signs, laboratory studies and agency room records were personally reviewed.  Case was also discussed directly with the emergency room provider.  2/2/22: Patient is a 68-year-old female who presents from the nursing home with increasing shortness of breath, hypoxia and COVID positive.  A full history of present illness could not be had as the patient is nonverbal since having a hemorrhagic stroke with resultant left-sided hemiplegia and the past patient also is NPO and has a G-tube.  Patient was found to be having hypoxia at the nursing home with O2 saturations in the 80% range, it is believed that the patient is chronically on supplemental O2 via nasal cannula.  EMS were notified who did give the patient a nebulizer treatment and increased her oxygen which improved her saturations into the low 90s.  No further information could be had from the patient.  The patient's medical history, current medications, imaging studies, vital signs, laboratory studies and agency room records were personally reviewed.  Case was also discussed directly with the emergency room provider.   Patient is mostly nonverbal as above.  She had a new PE, currently was on Xarelto past.  She was initially started on a IV heparin, subsequently Lovenox.  Will change her to Eliquis at discharge.  Patient was also continued on Decadron Levaquin.  The she will be continued on tube feeds as instructed.  Accu-Cheks q.6 hours with basal Lantus and a sliding scale insulin coverage with Humalog.  Patient was weaned off of oxygen.  She is hemodynamically stable, medically stable to be discharged back to skilled nursing facility today.
numbness; numbness; ache on the left side of her face; ache on the left side of her face; aches in her arm; general mild achiness; headache; fatigue; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), PAIN IN EXTREMITY (aches in her arm), PAIN (general mild achiness), the first episode of PAIN (ache on the left side of her face) and the first episode of HYPOAESTHESIA (numbness) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, the patient experienced PAIN IN EXTREMITY (sore arm) and FATIGUE (fatigue). On 20-Feb-2021, the patient experienced PAIN IN EXTREMITY (aches in her arm), PAIN (general mild achiness) and HEADACHE (headache). On 21-Feb-2021, the patient experienced the first episode of PAIN (ache on the left side of her face) and the second episode of PAIN (ache on the left side of her face). On 24-Feb-2021, the patient experienced the first episode of HYPOAESTHESIA (numbness) and the second episode of HYPOAESTHESIA (numbness). The patient was treated with Ibuprofen at an unspecified dose and frequency. On 21-Feb-2021, PAIN IN EXTREMITY (sore arm), PAIN IN EXTREMITY (aches in her arm), PAIN (general mild achiness) and HEADACHE (headache) had resolved. On 22-Feb-2021, FATIGUE (fatigue) had resolved. On 24-Feb-2021, last episode of PAIN (ache on the left side of her face) had resolved. At the time of the report, last episode of HYPOAESTHESIA (numbness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant information were not provided by the reporter.
Diagnosed with having a non-STEMI heart attack; Patient woke up and room was spinning (Vertigo); Dizzy; Nauseous; Throwing up; Chest pain; This spontaneous case was reported by a consumer and describes the occurrence of ACUTE MYOCARDIAL INFARCTION (Diagnosed with having a non-STEMI heart attack), VERTIGO (Patient woke up and room was spinning (Vertigo)), DIZZINESS (Dizzy), NAUSEA (Nauseous), VOMITING (Throwing up) and CHEST PAIN (Chest pain) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     No Medical History information was reported.  On 31-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Aug-2021, the patient experienced ACUTE MYOCARDIAL INFARCTION (Diagnosed with having a non-STEMI heart attack) (seriousness criteria hospitalization and medically significant), DIZZINESS (Dizzy) (seriousness criterion hospitalization), NAUSEA (Nauseous) (seriousness criterion hospitalization), VOMITING (Throwing up) (seriousness criterion hospitalization prolonged) and CHEST PAIN (Chest pain) (seriousness criterion hospitalization). 08-Aug-2021, the patient experienced VERTIGO (Patient woke up and room was spinning (Vertigo)) (seriousness criterion hospitalization). The patient was hospitalized from 08-Aug-2021 to 12-Aug-2021 due to ACUTE MYOCARDIAL INFARCTION, CHEST PAIN, DIZZINESS, NAUSEA, VERTIGO and VOMITING. At the time of the report, ACUTE MYOCARDIAL INFARCTION (Diagnosed with having a non-STEMI heart attack), VERTIGO (Patient woke up and room was spinning (Vertigo)), DIZZINESS (Dizzy), NAUSEA (Nauseous), VOMITING (Throwing up) and CHEST PAIN (Chest pain) outcome was unknown.  DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Aug-2021, Blood pressure measurement: 224/113 (High) 224/113.  The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.  Concomitant medications included heart medicine, cholesterol and high blood pressure medicine.  Treatment information was not provided.  Company comment: Very limited information regarding the events of acute myocardial infarction and chest pain has been provided at this time, additional information required. A causal relationship cannot be excluded for the events of vomiting, nausea, vertigo and dizziness; Sender's Comments: Very limited information regarding the events of acute myocardial infarction and chest pain has been provided at this time, additional information required. A causal relationship cannot be excluded for the events of vomiting, nausea, vertigo and dizziness.
Headache, Fever (slightly over 100), Chills, Body Aches all over, Fatigue (recovered from all so far except the fatigue and body aches all over)
Doctor's office reported the patient presented with red swelling adjacent to probable injection site. Area was hot to the touch and hard, treated as an allergic reaction and patient was dosed with 60mg of kenalog IM. Patient will continue to follow up with MD.
This spontaneous report as received from a nurse refers to unspecified patient of unknown age and gender. No medical history and current conditions were reported. The nurse reported that on an unknown date unknown number of patients were vaccinated with that doses of LIQUID PEDVAXHIB (unspecified dose and route) (lot K019700 expiry date 16-JUL-2017). On an unspecified date the vaccine had been improperly stored. The outcome of event was unknown. No adverse effects reported. Product quality complaint (PQC) was not reported. No further information provided. This is one of several reports received from the same reporter. Additional information has been requested.
Pain at the shot site, dizziness, tired, flushed cheeks, achy.
Noticed a rash on my neck while taking my shower on Friday 22nd... last Covid shot was Tuesday 19th
BACK PAIN; MIGRAINE; BODY PAINS; SHOULDER PAIN; PROLONGED NAUSEA; FATIGUE; This spontaneous report received from a patient concerned a 48 year old female. The patient's height, and weight were not reported. The patient's past medical history included neck injury, and concurrent conditions included migraines. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: UNKNOWN) dose was not reported, administered on 15-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the subject experienced back pain, migraine, body pains, shoulder pain, prolonged nausea, and fatigue. Treatment medications (dates unspecified) included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from migraine, was recovering from prolonged nausea, and fatigue, had not recovered from shoulder pain, and back pain, and the outcome of body pains was not reported. This report was non-serious.
Fever or Chills  Cough  Fatigue  Muscle or body aches  Headache  New loss of taste or smell  Congestion or running nose VERTIGO/DIZZINESS
Chills during night of injection.  Fever and general malaise starting on 3rd day (11/19/22)  Tested positive for Covid.  continues feeling poorly until about Wednesday 11/23.
Developed Rheumatoid Arthritis-- Pain began within 5 days of last dose of GARDASIL vaccination.  Severe joint pain--unable to walk.  2/26/09 Received PCP vaccine records & medical records of 1/2-8/29/2008. FINAL DX: Rheumatoid arthritis Records reveal patient had known right knee, left hip & low back pain.  By 2/08 had diffuse joint swelling while at college & seen in student health where CRP & RA factor both (+).  Referred to Rheum.  Tx w/steroids, plaquenil, methotrexate & humira.  Right knee synovial fluid drained 6/08.  RTC 7/08 w/right heel pain x 1 mo.  Dx w/right Achilles tendonitis.  Referred to ortho but did not go.  RTC 8/08 w/probably genital herpes & oral cold sores.  Tx w/antivirals.  Symptoms did not resolve, seen in student health & dx w/impetigo.  3/4/09 Received Rheum medical records of 2/08-12/08. FINAL DX: intensely inflammatory additive symmetrical polyarthritis w/flagrant synovitis while on steroids Records reveal patient experienced joint pain, swelling & stiffness beginning 12/07. Exam revealed multiple sites of synovitis, right knee warmth & effusion.  Tx w/additional meds of hydroxychloroquine & methotrexate.  Humira added later as s/s persisted.
Ongoing hospitalization with congestion, shortness of breath. Symptoms began 2 weeks prior to hospitalization with runny nose, sore throat, productive cough of white sputum and shortness of breath. SOB progressively wosensed. Diarrahe afor couple of days, water loose stool without blood.
Feeling sick; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Feeling sick) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 016M20A and 029A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MALAISE (Feeling sick). At the time of the report, MALAISE (Feeling sick) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not reported. Treatment information in response to events was not provided.   This case was linked to MOD-2021-036271 (E2B Linked Report).; Sender's Comments:  MOD-2021-036271:For the same reporter (Daughter case)
Information has been received from an office manager concerning a 62 year old male patient, who on 16-DEC-2004 was vaccinated with the first dose of PNEUMOVAX 23 (lot #, expire date and route not reported). On 01-NOV-2010 the patient received the second dose of PNEUMOVAX 23 (lot # 665903/1427Y) (expire date and route not reported). On 01-NOV-2010, the patient had a local and systemic reaction. He developed a fever of 101, injection site reaction. He was seen in the office but no treatment was recommended. At the time of the report, the outcome of the patient was unknown. Follow up information has been received from the office manager concerning the male patient. The office manager stated that the patient was vaccinated from a five dose of PNEUMOVAX 23 vial. It was reported that the patient had a local reaction with fever and that the patient recovered with no problems (date unknown). This is one of several reports received from the same source. Additional information is not expected.
Later in the day, patient developed pruritic erythematous rash near site of injection (left upper arm) and chest; there was no cough, wheeze, shortness of  breath, chest tightness, or GI symptoms. Rash still present 3 days later.
Information has been received from a physician concerning a 20 year old female with an allergy to antibiotics who on 16-Nov-2006 was vaccinated with a first dose of Gardasil vaccine (yeast). On 17-Nov-2006 the patient developed pain at the injection site. The patient began to have joint pain throughout her body. The location of the joint rotated and was in her right knee at the time of this report. Laboratory evaluations revealed that erythrocyte sedimentation rate and complete blood count were normal. The patient was to be seen by a neurologist. The physician reported that she would most likely hold off on the second dose of Gardasil vaccine (yeast). At the time of this report, the patient's joint pain persisted. Additional information has been requested. This is in follow-up to report (s) previously submitted on 1/16/2007.  Information has been received from a physician concerning a 20 year old female with an allergy to antibiotics who on 16-NOV-2006 was vaccinated with a first dose of GARDASIL.  On 17-NOV-2006 the patient developed pain at the injection site.  The patient then began to have joint pain throughout her body.  The location of the joint rotated and was in her right knee at the time of this report.  Laboratory evaluations revealed that erythrocyte sedimentation rate and complete blood count were normal.  The physician reported that the patient was seen by a rheumatologist, but she did not have the details of the visit.  The physician reported that the patient cancelled her appointment to received her second dose of GARDASIL.  At the time of this report, the patient's joint pain persisted.  Additional information has been requested.
1st day after the 2nd shot I was tired and achy. The next day I started having muscle spasms in my left clavicle and left neck area.  This progressed to my left ear having an ongoing and intermittent vibrating sensation. After a week, these muscle spasms and vibrations continue and, in addition, the hearing in my left ear is now muffled and I am hearing big pitched ringing in this left ear. The shot was almost 3 weeks ago and these symptoms remain ongoing, persistent, and progressive.
arm swelling/real puffy like it was so swollen; it may itch if irritated; Information has been received from an 82-year-old female patient with breast cancer, reporting on herself. The patient's medical history included breast operation. Concomitant therapies included atorvastatin, levothyroxine sodium, losartan potassium (manufacturer unknown) and venlafaxine hydrochloride.  The patient's drug reactions/allergies were not provided.   On 09-AUG-2019, the patient was vaccinated a with a dose of zoster vaccine live (ZOSTAVAX) (dosage, route, lot # and expiration date were not provided) in the left arm for prophylaxis.   The patient stated that right after the vaccination, her arm started to become swollen and then "it just kept going and was quite swollen" (peripheral swelling). It was reported that her arm got just a little better but then once a while it got worse. The patient explained that "after an airplane ride it got worse" and the swelling "went way down to her fingers". The patient also explained "sometimes it just happens during the day", it maybe twice a wee it gets worse and then just a little better. She has not had any pain, but the arm "may itch if irritated". Her left arm was "real puffy like it was so swollen". As a treatment, the patient took "TUMERX" (therapy unspecified) for a month or two, but she did not really notice any difference. At the time of the report, the patient had not recovered form peripheral swelling and pruritus. The causality assessment between the events and suspect therapy was not provided.
Some brain fog and irregular period after 1st dose, dizziness from turning head. Lingered for several weeks (2-3). After second dose, 10 hours after shot, 101-degree fever, chills. Was fine the next day, normal temperature. Then developed bronchitis around February, again in July. Have had persistent asthma, became significantly worse after vaccine dose. Went to pulmonologist. Given oral steroids back in winter, 4 times in total. Steroid inhaler, nebulizer machine, inhalant steroid disc, bronchodilator, albuterol inhaler, albuterol nebulizer, BUCP used with machine on daily basis. Going for CAT Scan soon. No longer able to work because of the extent of the symptoms.
swollen lips and tongue and rash I woke at 8 am with swollen lips and my tongue felt funny. I took 50 mg of benadryl at 815, at 830 I took zyrtec 10 mg and went to the ER.  At 945 they gave me a shot of decahedron and discharged me at 10 30 with prescription for oral steroids, epi pen and instructions to take pepcid, zyrtec twice daily and benadryl as needed.
Reported dizziness about 10 minutes after the vaccine.  Placed on a stretcher. BP 149/77, HR 77.  Observed for 30 minutes.  BP was 143/67, HR 73. Patient felt better and released.
Information has been received from a healthcare worker referring to a patient of unknown age and gender. The patient's medical history was not reported. On 21-JAN-2015 the patient was received improperly stored (Oka/Merck) VARIVAX (lot # K007979, expiration date, dose and route unknown). Concomitant medication was not reported. No adverse effects were reported. No product quality issue (PQC) was involved. This is one of several reports received from the same source. Additional information is not expected since the reporter don't wish us to contact.
she began experiencing neck and shoulder pain; she began experiencing neck and shoulder pain; This is a spontaneous report from a contactable consumer (Patient). A 43-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot Number: Unknown, Expiration date: Unknown) via an unspecified route of administration in Right Arm on 02Jun2021 at 16:10 (Age at vaccination 43-year) as single dose for COVID-19 immunization. Medical history included gout from Jan2021 if ongoing. The patient's concomitant medications were not reported. The patient received first dose of BNT162B2(Batch/Lot Number: Unknown, Expiration date: Unknown) administered on 07May2021 13:30 in right shoulder for COVID-19 immunization. The patient states she took the vaccine for her mother because her mother is 72 and had kidney cancer. Patient states she lives at home with her mother. The patient also states her mother has arthritis and she has problems with degenerative discs in her back. On 06Jun2021 the patient reported she began experiencing neck and shoulder pain. The seriousness of the events was reported as non-serious. The clinical outcome of the events was not recovered.  Follow-up attempts are needed; information about lot/batch number is requested.
Red, swollen area below injection site warm to touch. Given ice pack. Area marked/circled with instruction to seek medical attention if bigger than circled area. KEFLEX 1000 mg BID x 10 days.
My face got tight; Got very hot; Sharp pain down spine; Hard to breath; Racing heart lasting about 3-4 minutes; pain throughout the body; teeth chattering chills (over 2 hours); This is a spontaneous report from a contactable consumer, the patient. A 52-years-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: en6199) via an unspecified route of administration in the left arm on 04Mar2021 at 11:15 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. Medical history included multiple sclerosis on an unknown date. The patient did not have any allergies to food, medications or other products. Concomitant medications included glatiramer acetate (COPAXONE) at a dose of 40 mg from an unknown date for an unknown indication, other items not listed due 2 space. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 04Mar2021 at 19:30 the patient experienced face got tight, got very hot, sharp pain down spine, hard to breath, racing heart lasting about 3-4 minutes, pain throughout the body and teeth chattering chills (over 2 hours). The events were right after giving copaxone shot (over 24 hours from COVID). The patient did contact MS doctor but they felt it was a blood vessel. No therapeutic measures were taken as a result of reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events face got tight, got very hot, sharp pain down spine, hard to breath, racing heart lasting about 3-4 minutes, pain throughout the body and teeth chattering chills (over 2 hours) was recovered on an unknown date in 2021.   No follow-up attempts are needed. No further information is expected.
Pt recvd vax day 3 of upper resp illness w/fever; well appearing day of shots, approx 8PM t104 responded to APAP; 12AM t105.6 documented @ home; seen 130AM in ER 104.3;
Patient experienced headache, backache, stomach ache and all around malaise for 2 days following the shot.  She is feeling better now.  She did not experience any adverse effects with the first 3 moderna shots.
This spontaneous report was received from a medical assistant and refers to a 6 year old patient of unknown gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided. The medical assistant reported that on 18-AUG-2016 and on 30-AUG-2017, patient was intramuscularly vaccinated with GARDASIL 9 (dose, lot# and expiration date were not reported). No known adverse effects were reported.
then tested positive for Covid-19 on Sunday; then tested positive for Covid-19 on Sunday; This is a spontaneous report from a non-contactable consumer (parent). An unspecified age female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via unspecified route of administration, on 08Mar2021, as a single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. It was reported that patient received first dose of vaccine and undergone COVID-19 test and resulted in positive on an unknown date in Mar2021, Sunday (as reported). The patient concerned that she wanted to know what they should do about the 2nd dose. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.